Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency (Details Narrative)

v3.7.0.1
Stockholders' Deficiency (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Number of shares issued during period     $ 230,000    
Stock based compensation $ 921,683 $ 280,792 $ 1,088,931 $ 842,038  
Unrecognized stock option weighted average remaining vesting period     4 months 17 days    
Unrecognized stock based compensation expense related to stock option 4,432   $ 4,432    
Series C Convertible Preferred Stock [Member]          
Stock issued during period value stock dividend         $ 1,150,100
Warrants [Member]          
Number of shares issued during period, shares     3,550,000    
Shares converted into stock     4,546,300    
Consulting Agreement [Member]          
Number of shares issued during period, shares     1,058,314    
Series B Convertible Preferred Stock [Member]          
Number of shares redeemed during period         2,750
Number of shares redeemed during period, value         $ 275,000
Preferred stock liquidation preference $ 825,000   $ 825,000    
Series C Convertible Preferred Stock [Member]          
Number of shares issued during period, shares     61,740    
Number of shares issued during period     $ 6,200,000    
Preferred stock description     The Warrant Exchange is effective immediately and the Series C Preferred Stock Exchange is effective upon the closing of the public offering (collectively defined as a public offering of securities to raise up to $20,000,000 and to list the Company’s shares of common stock on the NASDAQ). The Series C Preferred Stock shall be exchanged for common stock using the following formula: the number of shares of Series C Convertible Preferred Stock owned multiplied by a factor of 115 and divided by 80% of the price per share of common stock sold in the in the public offering. Certain holders also agreed to not, without prior written consent of the underwriter, sell or otherwise transfer any shares of common stock or any securities convertible into common stock for a period of 270 days from the effective date of the Series C Preferred Stock Exchange. Subsequent to June 30, 2017, the Company issued an aggregate of 4,546,300 shares of common stock in connection with the Warrant Exchange.    
Shares converted into stock     12,678    
Warrant exercise price $ 0.70   $ 0.70    
Stock issued during period value stock dividend     $ 790,900    
Accrued and unpaid dividends $ 22,007,500   $ 22,007,500    
Series C Convertible Preferred Stock [Member] | Warrants [Member]          
Number of shares issued during period, shares     8,096,300    
Number of warrant to purchase of common stock shares 8,158,800   8,158,800    
Warrant exercise price $ 0.70   $ 0.70